Clinical meaning
Borderline lab values fall in a gray zone between clearly normal and clearly abnormal reference ranges, requiring the NP to integrate clinical context, pre-test probability, and patient-specific factors to determine clinical significance. Reference ranges are statistically derived — they represent the central 95% of values in a healthy reference population, meaning 5% of healthy individuals will fall outside the range by definition. Biological variation introduces further complexity: intra-individual coefficient of variation (CV) differs by analyte — serum sodium has a CV of approximately 0.6% (very stable), while serum ferritin has a CV of approximately 15% (highly variable). When a value falls near the reference range boundary, the NP must consider whether the result represents true pathology, biological variation, or pre-analytical error. Critical delta checks compare current values to prior results — a hemoglobin drop from 14.0 to 11.5 g/dL (both within some reference ranges) is clinically significant even if the current value is technically normal. The concept of positive and negative predictive value is essential: a borderline TSH of 5.2 mIU/L (upper limit 4.5-5.0) has very different implications in a patient with fatigue, weight gain, and dry skin versus an asymptomatic patient with recent illness (sick euthyroid). Bayesian reasoning dictates that the same lab result means different things depending on pre-test probability — a borderline fasting glucose of 105 mg/dL in an obese patient with family history of diabetes demands different follow-up than the same result in a lean athletic patient who ate 2 hours before the draw.